SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

ASLAN Pharmaceuticals to Initiate Trial of Eblasakimab in Atopic Dermatitis Patients

ASLAN Pharmaceuticals to Initiate Trial of Eblasakimab in Atopic Dermatitis Patients

MT Newswires · 09/14/2022 04:04

Please log in to view news